Retrospective Cohort Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 12,400
- 试验地点
- 1
- 主要终点
- Clinical biochemical indicators test
研究概览
简要总结
A retrospective cohort study was performed in patients with angina pectoris who were treated with oral Chinese patent medicine and Western medicine.The hospital's medical record management system was used to collect symptoms of angina pectoris, dose and frequency of nitroglycerin use, clinical biochemical test and imaging examination.To explore the clinical efficacy of Chinese patent medicine in the treatment of coronary heart disease with angina pectoris, and provide reliable data support for its clinical application.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 35 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 35-75 years old, gender is not limited;
- •Admission time is September 1, 2014 - September 1, 1919;
- •Patients with coronary heart disease and angina pectoris in the Department of Cardiology or Outpatient Department, the diagnosis of angina pectoris meets the diagnostic criteria of Western medicine and the standard of TCM syndrome differentiation;
- •Patients who met the criteria for drug treatment, the exposed group was treated with traditional Chinese medicine combined with Western medicine, and the non-exposed group was treated with Western medicine alone.
排除标准
- •Combined with other heart diseases, neurosis, menopausal syndrome, hyperthyroidism, cervical or vertebral artery type cervical spondylosis, gastro-oesophageal reflux disease or esophageal hiatus hernia may cause chest pain;
- •patients with acute myocardial infarction, heart failure, myocarditis, cardiomyopathy, severe heart valve disease, liver failure or renal failure, malignant tumors and severe metabolic diseases, as well as patients with severe symptoms and uncontrollable angina;
- •Pregnant women, lactating women or women of childbearing age who have birth requirements;
- •Mental patients, or cognitive dysfunction;
- •The investigator believes that there are other situations that are not suitable for the trial.
研究组 & 干预措施
Exposed group
Chinese patent medicine combined with western medicine routine treatment
干预措施: Chinese patent medicine (Drug)
结局指标
主要结局
Clinical biochemical indicators test
时间窗: one year
Film degree exam
时间窗: one year
Symptoms of angina
时间窗: one year
Dosage and frequency of use of nitroglycerin
时间窗: one year
次要结局
未报告次要终点
研究者
Chunquan Yu
Director
Tianjin University of Traditional Chinese Medicine